Omni Bio Pharmaceutical, Inc. filed its 10-K on Jun 28, 2013 for the period ending Mar 31, 2013. In this report its auditor, Hein & Associates LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +66.67% | +233.33% |
2016 | Omni Bio Pharmaceutical, Inc. cancelled the transaction announced on March 16, 2015 | CI |
2015 | Omni Bio Pharmaceutical, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+233.33% | 50.06K | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- OMBP Stock
- News Omni Bio Pharmaceutical, Inc.
- Omni Bio Pharmaceutical, Inc. Auditor Raises 'Going Concern' Doubt